Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Medicines derived from cannabis: A review of adverse events

Researchers at the McGill University Health Centre (MUHC), McGill University and the University of British Columbia (UBC) determined that medical use of cannabinoids do not cause an increase in serious adverse events, but are associated with an increase in some non-serious adverse events.

Several drugs containing compounds derived from the cannabis plant, or cannibinoids, are available for medical purposes in Canada. As the use of cannabinoid medications increases, so do concerns about their potential to cause “adverse events,” or negative side effects. Dr. Mark Ware, Dr. Stan Shapiro and PhD candidate Tongtong Wang of the Research Institute of the McGill University Health Centre and McGill University, and Dr. Jean-Paul Collet of the University of British Columbia examined the nature of these potential adverse events in a study which will be published June 16 in the Canadian Medical Association Journal (CMAJ).

The study was based on the adverse events reported in 31 separate clinical studies of cannabinoid medications conducted between 1966 and 2007. Adverse events were categorized as either serious or non-serious; with serious adverse events defined as those leading to death, hospitalization or disability.

“Overall, we found an 86% increase in the rate of non-serious adverse events among the patients treated with cannabinoids compared to the patients in the control groups,” said Ware, a neurosciences researcher at the Research Institute of the MUHC and assistant professor in anesthesia at McGill’s Faculty of Medicine The majority of events were mild to moderate in severity.

The majority of non-serious adverse events observed affected the nervous system, mainly dizziness and drowsiness. “Cannabinoids are used as medicines because they are neurologically active, so we expected to see some side effects such as these,” said Wang, a PhD candidate in epidemiology and biostatistics at McGill University.

Cannabinoids have been shown to treat chronic pain resulting from diseases such as cancer, multiple sclerosis, arthritis and fibromyalgia, and also to stimulate appetite and relieve nausea. Physicians must weigh the possible benefits of treatment against the possible side effects in an overall attempt to improve the patient’s quality of life.

“We have summarized the adverse events from these studies to help educate physicians and patients about the possible risks of medical cannabinoids,” said Collet, formerly at McGill’s Department of Epidemiology, and now professor at University of British Columbia, senior researcher at the Child & Family Research Institute and Director of the Centre for Applied Health Research and Evaluation at British Columbia Children’s Hospital. “We cannot extend these results to smoked cannabis or recreational use. That will require further research.”

This study was funded by a grant from Canadian Institutes of Health Research, and by a contribution from the Fond de recherche en santé du Québec.
_____________
source: McGill University Health Center

More Treatment & Detox Articles

Former alcoholic turns savior

Until 2002, Kumar Dhakal, 51, of Surkhet was a respected journalist, a teacher and a responsible family man. In the five years that followed, that image was shattered as Dhakal made a descent into the abyss of alcohol abuse. He lost his job and was incapable of shouldering family responsibilities. “In those dark years, there….

Irish spend three times EU average on alcohol

Irish people spend almost three and a half times more of their income on alcohol than the European average, an EU-wide survey reveals. A study on household expenditure across the 27 EU member states highlights how Irish consumers are the biggest spenders in Europe on alcohol by a long distance. It estimates that more than….

Teen alcoholic tells of battle with the bottle

Jesse is 23-years-old and should be able to have a beer with his mates. Instead he is an alcoholic. After leaving school at 16 to take up a chef apprenticeship, he began regularly drinking with his older work mates, then slowly watched his life spiral out of control as he went on three or four….

Anchorage center to commit alcoholics for detox

A new specialized treatment unit will open later this month in Anchorage to accept alcoholics involuntarily committed to a detoxification program. The unit is an attempt to intervene with street alcoholics who cannot make good choices for themselves, Robert Heffle, director of the Salvation Army’s Clitheroe Center, told The Anchorage Daily News in a story….

Opiate detox

Opiate intake regularly can lead to disorders related to the central nervous system. In an opiate addiction, the person is habitual to taking opiate drugs for “pain management”. This constant use of the opiates, affects the functioning of the nerve cells that results in the end of the “natural endorphins” production, which are capable of….